Missing/wrong data?
Log in to edit
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
scientific article published on 10 July 2014
Author/s
author: Paul Haluska, Diane C. Bodurka, Patricia S. Braly, Ursula A. Matulonis, Susana Banerjee
Work details
Publication date
July 10, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.